论文期刊

取消

高级检索

检索历史清除

首页> Lung cancer (Amsterdam, Netherlands)> MiR-320a is associated with cisplatin resistance in lung adenocarcinoma and its clinical value in non-small cell lung cancer: A comprehensive analysis based on microarray data.

MiR-320a is associated with cisplatin resistance in lung adenocarcinoma and its clinical value in non-small cell lung cancer: A comprehensive analysis based on microarray data.

导出 LinkOut

翻译打印收藏纠错

第一作者： Min,Lu

第一单位： Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.

作者： Min,Lu ^[1] ; Chunhong,Hu ^[1] ; Fang,Wu ^[2] ; Long,Shu ^[1] ; Yue,Pan ^[1] ; Xianling,Liu ^[1] ; Ping,Liu ^[1] ; Fang,Ma ^[1] ; Chao,Deng ^[1] ; Ming,Huang ^[1]

作者单位： Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China. ^[1] Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China; Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China; Hunan Key Laboratory of Early Diagnosis and Precision Therapy in Lung Cancer, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China. Electronic address: wufang4461@csu.edu.cn. ^[2]

关键词 5-Aza-2′-deoxycytidine A549/DDP Bioinformatics analyses Cisplatin Epigenetic therapy Lung adenocarcinoma MiR-320a Non-small cell lung cancer Reversal of chemoresistance Trichostatin A

主题词抗肿瘤药(Antineoplastic Agents);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);细胞系, 肿瘤(Cell Line, Tumor);顺铂(Cisplatin);抗药性, 肿瘤(Drug Resistance, Neoplasm);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);肺肿瘤(Lung Neoplasms);微RNAs(MicroRNAs)

DOI 10.1016/j.lungcan.2020.06.020

PMID 32731058

发布时间 2022-05-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Lung cancer (Amsterdam, Netherlands)

193-197页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷